<main lang="en" role="main" class="html-publication">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/uk-health-security-agency">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Outcome of the evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens (lateral flow devices) 
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 2 February 2022</p>

  </header>



<div data-module="sticky-element-container" class="govuk-grid-row sidebar-with-body">

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-e98134ae65ff5fe99a524d8c383350b3998f91c298dc24b36126e65f1656c578.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices
</p>


    </div>
  </div>

  <div class="main-content-container offset-empty-contents-list">
    <div class="gem-c-govspeak-html-publication">
  
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak ">
    
    
      <div class="govspeak">
<h2>Background</h2>

<p>Since its establishment in August 2020, the joint <abbr title="United Kingdom">UK</abbr> Health Security Agency (<abbr title="UK Health Security Agency">UKHSA</abbr>) Porton Down and University of Oxford SARS-CoV-2 lateral flow antigen test validation cell has evaluated over 160 lateral flow devices that have been referred by the Department of Health and Social Care.</p>

<p>Approximately 30% of the tests that were referred for validation met the standards for phase 2 validation, which are set out in the <a class="govuk-link" href="https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/protocol-for-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices">protocol for evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens</a>.</p>

<p><abbr title="UK Health Security Agency">UKHSA</abbr> Porton Down subsequently performed phase 3 testing to assess whether the lateral flow devices that passed phase 2 displayed performance characteristics desirable for mass population, community-based testing.</p>

<p>The desirable performance characteristics are:</p>

<ul>
  <li>very high specificity</li>
  <li>very high sensitivity against viral loads associated with infectiousness</li>
</ul>

<p>The lateral flow devices that display the desirable performance characteristics are summarised in table 1 below.</p>

<h3>Table 1: summary of lateral flow devices that have passed phase 3a validation</h3>

<table>
  <thead>
    <tr>
      <th scope="col">Lateral flow device</th>
      <th scope="col">Status</th>
      <th scope="col">Date evaluation completed</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th scope="row">Abbott Panbio COVID-19 Ag   Rapid Test Device</th>
      <td>Pass</td>
      <td>29 September 2020</td>
    </tr>
    <tr>
      <th scope="row">ACON Biotech Flowflex SARS-CoV-2   Antigen Rapid Test</th>
      <td>Pass</td>
      <td>19 February 2021</td>
    </tr>
    <tr>
      <th scope="row">Ameda AMP Rapid Test   SARS-CoV-2 Ag</th>
      <td>Pass</td>
      <td>12 March 2021</td>
    </tr>
    <tr>
      <th scope="row">Anhui DeepBlue COVID-19   Antigen Test Kit</th>
      <td>Pass</td>
      <td>23 October 2020</td>
    </tr>
    <tr>
      <th scope="row">Arista COVID-19 Antigen Rapid Test</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">Assure Tech Ecotest COVID-19 Antigen Nasal Test Kit (Biosafe Nasal ‘Pen’ Device)</th>
      <td>Pass</td>
      <td>14 January 2022</td>
    </tr>
    <tr>
      <th scope="row">Assure Tech Ecotest COVID-19 Antigen Rapid Test Device</th>
      <td>Pass</td>
      <td>20 July 2021</td>
    </tr>
    <tr>
      <th scope="row">Beijing Kewei COVID-19 Antigen Rapid Test Kit</th>
      <td>Pass</td>
      <td>21 May 2021</td>
    </tr>
    <tr>
      <th scope="row">BHM COVID-19 Antigen Sealing Tube Test Strip</th>
      <td>Pass</td>
      <td>14 January 2022</td>
    </tr>
    <tr>
      <th scope="row">Biopanda COVID-19 Rapid Antigen Test</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">Bioperfectus Technologies Novel Corona Virus Ag Rapid Test Kit</th>
      <td>Pass</td>
      <td>5 February 2021</td>
    </tr>
    <tr>
      <th scope="row">Biosynex COVID-19 Ag+ BSS</th>
      <td>Pass</td>
      <td>29 September 2021</td>
    </tr>
    <tr>
      <th scope="row">Biozek COVID-19 Antigen Rapid Test Cassette (Swab)</th>
      <td>Pass</td>
      <td>29 September 2021</td>
    </tr>
    <tr>
      <th scope="row">Core Tests COVID-19 Ag Test</th>
      <td>Pass</td>
      <td>17 December 2021</td>
    </tr>
    <tr>
      <th scope="row">DenScreen SARS CoV-2 Rapid Antigen Test: Non-Invasive Nostril Swab</th>
      <td>Pass</td>
      <td>3 August 2021</td>
    </tr>
    <tr>
      <th scope="row">DNA Diagnostic COVID-19   Antigen Detection Kit</th>
      <td>Pass</td>
      <td>20 January 2021</td>
    </tr>
    <tr>
      <th scope="row">Excalibur Rapid SARS-CoV-2   Antigen Test Card</th>
      <td>Pass</td>
      <td>22 January 2021</td>
    </tr>
    <tr>
      <th scope="row">Fortress Diagnostics Coronavirus   Ag Rapid Test</th>
      <td>Pass</td>
      <td>13 November 2020</td>
    </tr>
    <tr>
      <th scope="row">GenSure COVID-19 Antigen Rapid Test Kit</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">Getein   Biotech One Step Test for SARS-CoV-2 Antigen</th>
      <td>Pass</td>
      <td>10 March 2021</td>
    </tr>
    <tr>
      <th scope="row">Goldsite SARS-CoV-2 Antigen Kit (Colloidal Gold)</th>
      <td>Pass</td>
      <td>8 July 2021</td>
    </tr>
    <tr>
      <th scope="row">Hangzhou Clongene Biotech COVID-19 Antigen Rapid Test Cassette (Nasal Swab)</th>
      <td>Pass</td>
      <td>29 September 2021</td>
    </tr>
    <tr>
      <th scope="row">Hughes Veritas Rapid Antigen Test for SARS-CoV-2</th>
      <td>Pass</td>
      <td>21 May 2021</td>
    </tr>
    <tr>
      <th scope="row">Humasis COVID-19 Ag Test</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">Innova (Xiamen Biotime) SARS-CoV-2 Antigen Rapid Qualitative Test</th>
      <td>Pass</td>
      <td>11 September 2020</td>
    </tr>
    <tr>
      <th scope="row">Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold)</th>
      <td>Pass</td>
      <td>17 December 2021</td>
    </tr>
    <tr>
      <th scope="row">Kisshealth Rapid COVID-19 Self-Test Antigen Lateral Flow Device</th>
      <td>Pass</td>
      <td>17 December 2021</td>
    </tr>
    <tr>
      <th scope="row">Konsung COVID-19 Antigen Rapid Test Kit (Colloidal Gold)</th>
      <td>Pass</td>
      <td>8 July 2021</td>
    </tr>
    <tr>
      <th scope="row">Liming Bio StrongStep SARS-CoV-2   Antigen Rapid Test</th>
      <td>Pass</td>
      <td>2 March 2021</td>
    </tr>
    <tr>
      <th scope="row">Lyher Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold)</th>
      <td>Pass</td>
      <td>21 May 2021</td>
    </tr>
    <tr>
      <th scope="row">Mediport COVID-19 Antigen Rapid Test Kit</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">MP Biomedical Rapid SARS-CoV-2   Antigen Test Card</th>
      <td>Pass</td>
      <td>5 February 2021</td>
    </tr>
    <tr>
      <th scope="row">NADAL COVID-19 Ag plus test</th>
      <td>Pass</td>
      <td>17 December 2021</td>
    </tr>
    <tr>
      <th scope="row">Nantong Diagnos Biotechnology COVID-19 Ag Test</th>
      <td>Pass</td>
      <td>21 January 2021</td>
    </tr>
    <tr>
      <th scope="row">Orient Gene / Healgen Coronavirus   Ag Rapid Test (swab)</th>
      <td>Pass</td>
      <td>2 October 2020</td>
    </tr>
    <tr>
      <th scope="row">Roche SARS-CoV-2 Rapid Antigen Test Nasal / Self Test Nasal</th>
      <td>Pass</td>
      <td>21 May 2021</td>
    </tr>
    <tr>
      <th scope="row">Roche SD Biosensor Standard Q   COVID-19 Ag Test</th>
      <td>Pass</td>
      <td>2 December 2020</td>
    </tr>
    <tr>
      <th scope="row">Roche SD Biosensor Standard Q   COVID-19 Ag Saliva Test</th>
      <td>Pass</td>
      <td>9 February 2021</td>
    </tr>
    <tr>
      <th scope="row">Shenzhen YHLO GLINE-2019-nCoV Ag test</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">Surescreen SARS-CoV-2 Antigen   Rapid Test Cassette</th>
      <td>Pass</td>
      <td>2 December 2020</td>
    </tr>
    <tr>
      <th scope="row">Surescreen SARS-CoV-2 Antigen   Rapid Test Cassette v2</th>
      <td>Pass</td>
      <td>15 March 2021</td>
    </tr>
    <tr>
      <th scope="row">Surge COVID-19 Antigen Test Kit</th>
      <td>Pass</td>
      <td>3 August 2021</td>
    </tr>
    <tr>
      <th scope="row">Tigsun COVID-19 Antigen Rapid Test</th>
      <td>Pass</td>
      <td>29 September 2021</td>
    </tr>
    <tr>
      <th scope="row">Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)</th>
      <td>Pass</td>
      <td>25 June 2021</td>
    </tr>
    <tr>
      <th scope="row">Wuhan EasyDiagnosis COVID-19 (SARS-CoV-2) Antigen Test Kit</th>
      <td>Pass</td>
      <td>21 May 2021</td>
    </tr>
    <tr>
      <th scope="row">Xiamen Boson Biotech Rapid SARS-CoV-2 Antigen Test Card</th>
      <td>Pass</td>
      <td>29 September 2021</td>
    </tr>
    <tr>
      <th scope="row">ZandCell COVID-19 Antigen Test</th>
      <td>Pass</td>
      <td>18 March 2021</td>
    </tr>
    <tr>
      <th scope="row">Zhuhai ENCODE - SARS-COV-2 Antigen Rapid Test Device</th>
      <td>Pass</td>
      <td>29 September 2021</td>
    </tr>
  </tbody>
</table>

</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a href="#contents" class="govuk-link app-c-back-to-top dont-print">
    <svg height="17" xmlns="http://www.w3.org/2000/svg" width="13" class="app-c-back-to-top__icon" viewBox="0 0 13 17" focusable="false">
      <path fill="currentColor" d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button data-module="print-link" class="govuk-link govuk-body-s gem-c-print-link__button">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>